GSK's Rotavirus Vaccine Tied To Bowel Disorder

Law360, New York (June 16, 2011, 6:50 PM EDT) -- GlaxoSmithKline PLC's Rotarix has been linked to a serious bowel disorder in infants, but the benefits of the rotavirus vaccine far outweigh that risk, according to a study published Thursday in the New England Journal of Medicine.

The study tied the vaccine to a short-term risk of a bowel disorder called intussusception in one of every 51,000 to 68,000 vaccinated infants, researchers at the Centers for Disease Control and Prevention and a number of health agencies and hospitals in Brazil and Mexico revealed.

However, the number...
To view the full article, register now.